Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
or

Cordovacann Corp (LVRLF)

Cordovacann Corp (LVRLF)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0750 -0.0343 (-31.38%) 04/25/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0750 unch (unch) 13:23 ET
Profile for Fri, Apr 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.

Company Info

Cordovacann Corp

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Livereel Media Corp was incorporated under the Business Corporation Act, Ontario on March 18, 1997. It is an entertainment company. The Company is engaged in the financing, development, licensing, production and distribution of feature films, television series, television movies and non-fiction programming. Currently, the Company is engaged in preserving its cash by minimizing operating expenses, and looking to investment opportunities both within and outside of the film industry.

Key Statistics

Overview:

Annual Sales, $ 0 K
Annual Net Income, $ 0 K
Short Volume Ratio 0.08

Growth:

1-Year Return -15.73%
3-Year Return -73.78%
5-Year Return -73.91%

Per-Share Information:

Next Earnings Date N/A
Dividend Payout Ratio 0.00%

LVRLF Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % N/A
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share N/A
Interest Coverage N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective